cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.
about
MicroRNAs in the pathogenesis of cystic kidney diseaseSystems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney diseaseUrine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney diseasePharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial.Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease.The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effectsDoes increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patientsPolycystic kidney disease: In danger of being X-rated?Autopsy report with clinical and pathophysiologic discussion of autosomal dominant adult polycystic kidney diseaseParallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.CFTR inhibitors.Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway.Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 modelCyclic AMP-mediated cyst expansionNew insights into ciliary function: kidney cysts and photoreceptors.Cilium, centrosome and cell cycle regulation in polycystic kidney disease.c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formationFibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).Molecular pathways and therapies in autosomal-dominant polycystic kidney diseaseCFTR channel pharmacology: novel pore blockers identified by high-throughput screening.Vasopressin and disruption of calcium signalling in polycystic kidney disease.Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials DatabaseVasopressin antagonists in polycystic kidney disease.Src inhibition ameliorates polycystic kidney diseasePhosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptorCyclic nucleotide signaling in polycystic kidney disease.Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKDPhysiology and pathophysiology of the vasopressin-regulated renal water reabsorption.Purinergic signaling in the lumen of a normal nephron and in remodeled PKD encapsulated cysts.Novel roles of Pkd2 in male reproductive system developmentPolycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease.Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.Calcium-mediated mechanisms of cystic expansion.
P2860
Q26852641-F55E5F6F-77E3-4976-B77B-95ED213A73C2Q28587166-1D0F6696-A5BD-414F-8DAA-9D4D0CBECDFBQ31154416-D56FF824-643C-44AA-96F9-6AA385ED71A9Q33809680-1C3320F3-BAF3-4E4C-8E38-14FC491B6070Q33824148-BAFA3ACB-65A7-48DC-AB8E-92E366CFB0E9Q33873132-0B3298BB-D25B-4BB7-87D3-10624C1CC444Q33974670-EB84C34D-C3AB-483C-B756-70E36D938D29Q34086721-8469DD8A-E690-4C1D-8988-BF3496D91555Q34094366-D869B26D-6FE7-4E8E-913F-1E62E250B895Q34124758-08C43E7A-A675-46B7-9A3B-1B49E7B3F73EQ34131360-D5D3A2C9-D815-49B1-B00D-78A0A86622F9Q34278702-A91C0319-1301-4D71-939F-4BED11360CDDQ34551756-FA4616D3-8368-467E-BE86-7AAAFEAD8F66Q34553829-508B913D-16D8-4D5E-BBAB-215B162A614AQ34654407-37B59317-A1BC-4523-88AD-77540181E39DQ34787786-47F36C3F-0BAC-46C0-9215-E914AA9E997EQ34850793-1B64B6AC-D579-400E-A0B1-4428253B1055Q35021529-8AA76D33-1CFB-4D37-993A-8443F9C2F98CQ35112926-F9D36E85-435A-4477-BEE2-472DFDD75FFFQ35159468-06BA5460-1D86-4160-8DD3-A3A534F2939AQ35194509-6551A558-AD5C-4EF2-AF5A-EDDFE7018B00Q35578646-59B0B844-7B23-4777-A26B-1D70D6D8ECAFQ35847415-77C756B6-32B7-42A2-92FB-A95B16C3DE99Q35962991-4ECA5087-5F30-4392-89A4-F8EC35F2E30FQ36171663-F29D0347-0FC1-49FE-A200-F1516C0F81F0Q36697096-87467F92-DEA2-4314-AB24-C3A35E0C679EQ36736752-F84EAAE1-4057-4E1F-8F20-1D4125687920Q36746073-DCBE5DC8-4553-4910-8E17-C0C0C399CA1CQ36804714-BB89EBCC-0AAD-4254-96E0-372579FD9F96Q36977390-2B97952C-8B7E-42A7-B9FF-C7C18C24B064Q37051278-BD570D45-18E0-4BC4-B127-B7A11EC92B81Q37090843-E713A623-1674-486C-A2FB-8C5C8F55FC00Q37138836-FF99C437-96BA-4C8E-85ED-78C7B7217395Q37145917-47A6785D-1EF9-4067-A42A-050541DEB137Q37148393-4B02E9C4-8B5E-4BC5-9179-B2BB73067400Q37224754-54E90FD1-E72D-4158-A330-37DDCB71B1D0Q37479371-C97CDF11-FD97-426C-9A4F-7D35417A76FFQ37697510-89582184-1F33-41FC-A05B-07D817E5C48DQ37723395-4223E692-6954-48DE-AA83-59898533313EQ37798910-61D86A2D-33C5-47F6-B38D-7852B92D5EAF
P2860
cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
cAMP regulates cell proliferat ...... lycystic kidney disease cells.
@ast
cAMP regulates cell proliferat ...... lycystic kidney disease cells.
@en
type
label
cAMP regulates cell proliferat ...... lycystic kidney disease cells.
@ast
cAMP regulates cell proliferat ...... lycystic kidney disease cells.
@en
prefLabel
cAMP regulates cell proliferat ...... lycystic kidney disease cells.
@ast
cAMP regulates cell proliferat ...... lycystic kidney disease cells.
@en
P1476
cAMP regulates cell proliferat ...... olycystic kidney disease cells
@en
P2093
P304
P577
2000-07-01T00:00:00Z